Cargando…

In-silico study of influence of HLA heterogeneity on CTL responses across ethnicities to SARS-CoV-2

Differences in outcome to COVID-19 infection in different individuals is largely attributed to genetic heterogeneity leading to differential immune responses across individuals and populations. HLA is one such genetic factor that varies across individuals leading to differences in how T-cell respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Vishal, Chandra, Nagasuma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550298/ https://www.ncbi.nlm.nih.gov/pubmed/36229378 http://dx.doi.org/10.1016/j.humimm.2022.09.008

Ejemplares similares

Grouping of large populations into few CTL immune ‘response-types' from influenza H1N1 genome analysis
por: Mukherjee, Sumanta, et al.
Publicado: (2014)

Heterogeneity in SARS-CoV-2 Positivity by Ethnicity in Los Angeles
por: Allan-Blitz, Lao-Tzu, et al.
Publicado: (2021)

SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses
por: Schmidt, Katja G., et al.
Publicado: (2021)

Identification of HLA-A*24:02-Restricted CTL Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 and Analysis of Their Conservation Using the Mutation Database of SARS-CoV-2 Variants
por: Takagi, Akira, et al.
Publicado: (2021)

Identification of a promiscuous conserved CTL epitope within the SARS-CoV-2 spike protein
por: Jiang, Sheng, et al.
Publicado: (2022)

Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19
por: Rencilin, Clayton Fernando, et al.
Publicado: (2021)

SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly
por: Onnis, Anna, et al.
Publicado: (2022)

Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2—An in silico glance
por: Marchan, Jose
Publicado: (2020)

SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC)
por: Charonis, Spyros A., et al.
Publicado: (2022)

Residue analysis of a CTL epitope of SARS-CoV spike protein by IFN-gamma production and bioinformatics prediction
por: Huang, Jun, et al.
Publicado: (2012)

HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review
por: Abd El-Baky, Nawal, et al.
Publicado: (2023)

Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface Expression
por: Israeli, Moshe, et al.
Publicado: (2014)

Influence of HLA gene polymorphisms on susceptibility and outcome post infection with the SARS-CoV virus
por: Yuan, Fang Fang, et al.
Publicado: (2014)

Current HLA Investigations on SARS-CoV-2 and Perspectives
por: Douillard, Venceslas, et al.
Publicado: (2021)

A SARS-CoV-2 vaccine candidate: In-silico cloning and validation
por: Bhattacharya, Manojit, et al.
Publicado: (2020)

Exploring anti-malarial potential of FDA approved drugs: an in silico approach
por: Ramakrishnan, Gayatri, et al.
Publicado: (2017)

Forward Vaccinology: CTL Targeting Based upon Physical Detection of HLA-Bound Peptides
por: Reinherz, Ellis L., et al.
Publicado: (2014)

Identification of Novel HLA-A*0201-Restricted CTL Epitopes in Chinese Vitiligo Patients
por: Cui, Tingting, et al.
Publicado: (2016)

Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
por: Li, Meng, et al.
Publicado: (2023)

Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine
por: Chakraborty, Sajib, et al.
Publicado: (2014)

Analysis and Identification of Bioactive Compounds of Cannabinoids in Silico for Inhibition of SARS-CoV-2 and SARS-CoV
por: Chen, Chenxiao, et al.
Publicado: (2022)

HLA Variation and SARS-CoV-2 Specific Antibody Response
por: Wolday, Dawit, et al.
Publicado: (2023)

A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques
por: Harris, Paul E., et al.
Publicado: (2021)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

Spatial Heterogeneity and Peptide Availability Determine CTL Killing Efficiency In Vivo
por: Hogan, Thea, et al.
Publicado: (2014)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
por: Sada, Mitsuru, et al.
Publicado: (2020)

An in silico map of the SARS-CoV-2 RNA Structurome
por: Andrews, Ryan J., et al.
Publicado: (2020)

In silico antibody engineering for SARS-CoV-2 detection
por: Martí, Didac, et al.
Publicado: (2021)

T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations
por: Nersisyan, Stepan, et al.
Publicado: (2021)

Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA
por: Leslie, Alasdair, et al.
Publicado: (2005)

Polymorphisms within the SARS-CoV-2 Human Receptor Genes Associate with Variable Disease Outcomes across Ethnicities
por: Adimulam, Theolan, et al.
Publicado: (2023)

SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies
por: Wijtvliet, Veerle P.W.M., et al.
Publicado: (2022)

Comparative analysis of non structural protein 1 of SARS-CoV2 with SARS-CoV1 and MERS-CoV: An in silico study
por: Chaudhuri, Ankur
Publicado: (2021)

Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer
por: SAWADA, YU, et al.
Publicado: (2014)

In silico anti-SARS-CoV-2 activities of five-membered heterocycle-substituted benzimidazoles
por: Mudi, Prafullya Kumar, et al.
Publicado: (2022)

HLA repertoire of 115 UAE nationals infected with SARS-CoV-2
por: Alnaqbi, Halima, et al.
Publicado: (2022)

Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection
por: Lin, Aifen, et al.
Publicado: (2021)

Induction of pulmonary HLA-G expression by SARS-CoV-2 infection
por: Seliger, Barbara, et al.
Publicado: (2022)

Cellular heterogeneity and repolarisation across the atria: an in silico study
por: Elliott, Jordan, et al.
Publicado: (2022)

Transmission of HIV-1 CTL Escape Variants Provides HLA-Mismatched Recipients with a Survival Advantage
por: Chopera, Denis R., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_136hidltv6hejl79dsu6u8qtjc